Thrombin activatable fibrinolysis inhibitor promotes development of chronic thromboembolic pulmonary hypertension -A possible novel therapeutic target-
Innate immune nod1/rip2 signaling is essential for cardiac hypertrophic response with a surprising critical interaction with mitochondrial danger activator